Cambrex Completes Biopharmaceutical Expansion at its Durham, NC Facility
07 avr. 2020 08h45 HE
|
Cambrex Corporation
EAST RUTHERFORD, N.J., April 07, 2020 (GLOBE NEWSWIRE) -- Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle,...
Cambrex Appoints Troy Player as President, Early Stage Development & Testing Business Unit
31 mars 2020 08h00 HE
|
Cambrex Corporation
EAST RUTHERFORD, N.J., March 31, 2020 (GLOBE NEWSWIRE) -- Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle,...
Cambrex Announces Management Changes and Board Appointments
06 janv. 2020 11h36 HE
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Cambrex Corporation, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug...
Cambrex Announces Completion of Acquisition by the Permira Funds
04 déc. 2019 09h27 HE
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Dec. 04, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...
Cambrex Wins Third API Development Award at CPhI Worldwide
14 nov. 2019 07h30 HE
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Nov. 14, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...
Cambrex Releases Selected Preliminary Third Quarter 2019 Financial Results
24 oct. 2019 06h40 HE
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...
Cambrex Corporation Announces Expiration of “Go Shop” Period Under Merger Agreement
23 sept. 2019 06h40 HE
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM) (the “Company” or “Cambrex”) today announced the expiration, as of 12:01 a.m., Eastern Time, on September...
Cambrex Cancels Second Quarter Earnings Conference Call and Will Not Update Financial Guidance
07 août 2019 12h55 HE
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...
Cambrex to be Acquired by the Permira Funds for $60.00 per Share in Cash
07 août 2019 06h30 HE
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Aug. 07, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...
Cambrex to Announce Second Quarter 2019 Financial Results on August 9, 2019
06 août 2019 10h10 HE
|
Cambrex Corporation
EAST RUTHERFORD, N.J., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the...